new glp-1 drug Drugs: 6 Things We've Learned About Their Effects New study shows popular GLP-1
Description
The evidence reveals significant heterogeneity in the effects of GLP-1RAs across different cancer types
doi: 10.3390/nu11071664 50 WangYHeWWeiWMeiXYangMWangY
[DOI] [PMC free article] [PubMed] [Google Scholar] 84.Akbulut U.E., Isik I.A., Atalay A., et al
7 In patients who meet these criteria, the ADA preferably recommends use of a GLP-1 RA with proven cardiovascular benefit or an SGLT-2 inhibitor with proven cardiovascular benefit provided they have adequate kidney function
10.1016/0014-5793(94)01430-9 88 WeldyC
